Agenta Biotechnologies
  Capitalizing on a patented molecular proteoglycan technology platform
Overview
Personnel
Products / Technology
Targeted Diseases
Contacts
PressRoom



Agenta Biotechnologies, Inc.
Innovation Depot
1500 1st Ave. N., Suite L105
    Unit 31
Birmingham, AL  35203
Ph: (205) 307-6500
Fax: (205) 307-6501
Email: Agenta@agentabiotechnologies.com
www.agentabio.com
Purchasing; contact Dr. Ellis

Board of Directors
Arthur DeCarlo, DDS, Ph.D.
    President and Science Director, Agenta
Richard Furey, J.D.
    White & Case LLP Miami, Florida 33311

Science Advisory Board
John Whitelock, Ph.D.
    UNSW School of Biomedical Engineering
Ling Li, Ph.D.
    Scripps Florida Research Institute

Officers

President and CEO:
Dr. Arthur DeCarlo
Treasurer: Dr. Thomas DeCarlo
Secretary: Dr, Arthur DeCarlo

Research Staff
Dr. Arthur DeCarlo
Dr. April Ellis
Dr. Maria Belousova
Dr. Chuanyu Li
Dr. Thomas Dooley
Dr. John Whitelock
Dr. Patrick Hardigan
Dr. Don Petersen
Dr. Hernan Grenett










Agenta Biotechnologies, Inc. is a privately held Alabama C-corporation actively seeking research alliances and out-licensing opportunities.


Agenta Biotechnologies is a discovery-based biotechnology corporation and our quest for discovery is ongoing. 
Agenta's platform technology can maintain a strong pipeline of rationally derived therapeutic candidates, and Agenta will capitalize on its patent technology, realizing its untapped and enormous potential to improve or maintain the health of both young and old alike.


  got science?  Agenta Biotechnologies does.
order your "got science?" tee-shirt or cap from Agenta
(email orders to got_science@agentabio.com)
Specify tee-shirt or cap and # needed)  $20 per shirt or cap. Large order >25 price reduction. order or inquiries to got_science@agentabio.com.
US Trademark pending.

Tee-shirt image